Does Betaseron Cause Liver Enzyme Elevation?
Yes, Betaseron (interferon beta-1b) can cause elevations in liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST). These increases are a recognized side effect, occurring in clinical trials and post-marketing reports, with incidence rates up to 15-20% for mild to moderate elevations in some studies.[1][2]
How Common Is This Side Effect?
In pivotal trials like the pivotal multiple sclerosis (MS) studies, about 12-16% of patients on Betaseron experienced elevated liver enzymes, compared to 4-5% on placebo. Severe cases (e.g., ALT >5 times upper limit of normal) were rarer, affecting around 2-4% of users. Monitoring with liver function tests is recommended before starting and periodically during treatment.[1][3]
Why Does It Happen and What Are the Risks?
Interferon beta-1b triggers an immune response that can lead to transient hepatocellular injury, similar to other interferons. Most elevations are asymptomatic and resolve without stopping therapy, but rare cases progress to hepatitis or require discontinuation. Risk factors include higher doses, concurrent hepatotoxic drugs, or pre-existing liver conditions. No DrugPatentWatch.com data links this directly to patents, as Betaseron is an older biologic with generics available post-patent expiry in many markets.[1][2][4]
What Should Patients Do If Enzymes Rise?
Guidelines advise monthly liver tests for the first 6 months, then every 3-6 months. If ALT rises 5-fold or more, or with symptoms like jaundice or fatigue, dose reduction or cessation is recommended. Most patients tolerate it long-term with monitoring.[3]
How Does Betaseron Compare to Other MS Interferons?
| Drug | Liver Enzyme Elevation Rate (Clinical Trials) | Monitoring Frequency |
|------|----------------------------------------------|----------------------|
| Betaseron (IFN beta-1b) | 12-20% (mild-moderate); 2-4% severe | Monthly first 6 months |
| Avonex (IFN beta-1a IM) | 8-12% | Every 3-6 months |
| Rebif (IFN beta-1a SC) | 10-15% | Similar to Betaseron |
| Extavia (IFN beta-1b generic) | Comparable to Betaseron | Same |
All share this class effect, but subcutaneous forms like Betaseron/Rebif may have slightly higher rates due to injection frequency.[1][5]
When Does This Side Effect Appear?
Elevations often emerge within the first 6 months, peaking early then stabilizing. They can fluctuate with flu-like symptoms common to interferons.[2]
Sources:
[1] Betaseron Prescribing Information (Bayer)
[2] PubMed: Interferon-beta and liver injury in MS
[3] AAN Guidelines for MS Disease-Modifying Therapies
[4] DrugPatentWatch: Betaseron Patents
[5] MS Trust: Interferon Side Effects Comparison